Correlation between NT-proBNP, hsCRP and OXSR1: Clinical relevance in evaluating the prognosis of polytrauma patients

Introduction. Polytrauma patients are expected to have a higher risk of mortality than that obtained by the summation of expected mortality owing to their individual injuries. Subsequent life-threatening posttraumatic complications are associated with overproduction of proinflammatory mediators (e.g...

Full description

Saved in:
Bibliographic Details
Published inRevista medicală Română Vol. 68; no. 3; pp. 406 - 410
Main Authors Dumitru, Costin, Ripszky Totan, Alexandra, Stănescu-Spînu, Iulia-Ioana, Miricescu, Daniela, Greabu, Maria
Format Journal Article
LanguageEnglish
Published Amaltea Medical Publishing House 30.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Introduction. Polytrauma patients are expected to have a higher risk of mortality than that obtained by the summation of expected mortality owing to their individual injuries. Subsequent life-threatening posttraumatic complications are associated with overproduction of proinflammatory mediators (e.g. cytokines, chemokines) and the critical imbalance of cell-regulated innate immunity. Material and methods. The present study is aimed to identify a possible relationship between NT-proBNP, hs-CRP and OXSR1 biochemical markers in polytrauma patients, both by bibliographic research and quantitative analysis and statistics of some parameters of interest in lot of 46 patients. Results and discussions. The correlation between hsCRP and the inflammatory response after trauma is well-known and well documented in literature, so the negative correlation between hsCRP and OXSR1 that resulted from our analysis is of great significance resulting in a potentially new biomarker to be further studied and used in determining the possible outcome of polytrauma patients. Conclusion. Although OXSR1 is a new in the field of polytrauma patients, because is negatively correlated with hsCRP and the clinical evolution of the patients we think that OXSR1 is a good biomarker to further in investigate and may be used in determining the clinical progress of the polytrauma patients.
ISSN:1220-5478
2069-606X
DOI:10.37897/RMJ.2021.3.12